Replies to post #430609 on Anavex Life Sciences Corp (AVXL)

[Joseph_K]

They might claim it, but they don't show it. Where does it show "Reduction in decline of the ability to perform daily activities assessed from baseline over 48 weeks with ANAVEX2-73 compared to placebo using the Activities of Daily Living Scale (ADCS-ADL)"?

Don't you find it a bit odd that today's PR doesn't even mention ADCS-ADL, one of its advertised two primary endpoints?